title: Plasma endothelin-1 levels in patients with peripheral arterial occlusive disease at different Fontaine's stages.
abstract: Endothelin-1 (ET-1) is a potent vasoconstrictor and mitogenic peptide produced and secreted by endothelial cells, which can play a potential role in the development of atherosclerosis and in the pathophysiology of extreme vasoconstriction of various diseases.
  
  
  METHODS
  To assess plasma endothelin-1 (ET-1) concentrations in patients with peripheral arterial occlusive disease (PAOD) at different Fontaine's stages, we measured plasma ET-1 by radioimmunoassay in 14 stage II PAOD patients (12 men, 2 women; mean age 59.5 +/- 3.4 years) and in 10 stage III-IV PAOD patients (8 men, 2 women, mean age 61.2 +/- 3.3 years). Ten normal subjects (8 men, 2 women, mean age 58.1 +/- 7.2 years) were considered as controls.
  
  
  RESULTS
  Mean (+/- SD) plasma ET-1 levels, as measured by radioimmunoassay, were significantly greater in stage II and stage III-IV PAOD patients than in control subjects (4 +/- 0.4 and 5 +/- 0.4 pmol/L vs 2.5 +/- 0.6 pmol/L, respectively, p < 0.001). Furthermore, plasma levels of ET-1 in stage III-IV patients were significantly higher than in stage II patients (p < 0.01). A significant correlation was found between plasma ET-1 levels and number of the arterial obstructive lesions in PAOD patients (r = 0.698; p < 0.0001). No significant correlation was found between plasma ET-1 concentrations and pain-free walking distance (r = -0.279, p = 0.333, in stage II patients; r = 0.137, p = 0.705, in stage III-IV patients), and between plasma ET-1 levels and ankle/arm pressor index (r = 0.032, p = 0.913, in stage II patients; r = 0.149, p = 0.681, in stage III-IV patients) in the PAOD patients.
  
  
  CONCLUSIONS
  Raised plasma ET-1 could be a sensible marker both of endothelial damage and disease extension. It could also promote the progression of atherosclerotic plaques and enhance the microvascular resistance in these patients.
authors.affiliation: Institute of Internal Medicine L. Condorelli, University of Catania, Italy.
authors.forename: R A
authors.initials: RA
authors.lastname: Mangiafico
authors.forename: L S
authors.initials: LS
authors.lastname: Malatino
authors.forename: M
authors.initials: M
authors.lastname: Santonocito
authors.forename: F
authors.initials: F
authors.lastname: Sarnataro
authors.forename: S
authors.initials: S
authors.lastname: Dell'Arte
authors.forename: R
authors.initials: R
authors.lastname: Messina
authors.forename: B
authors.initials: B
authors.lastname: Santangelo
mesh_terms: D001157:Arterial Occlusive Diseases / Q000097:blood* / Q000145:classification; D016022:Case-Control Studies; D018450:Disease Progression; D019332:Endothelin-1 / Q000097:blood*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged
chemical_list: D019332:Endothelin-1